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Peripheral blood mononuclear cells from cattle experimentally infected with Babesia bovis were examined for
parasite-specific cell-mediated immune responses. Unfractionated merozoites and soluble and membrane
fractions derived from merozoites were all antigenic for imimune cattle, although the membrane fraction was
the most stimulatory. Cattle responded to different antigenic fractions in a differential manner, and only that
animal immunized with autologous cultured parasites responded to parasitized erythrocyte culture superna-
tants. Plastic-adherent cells (presumably monocytes/macrophages) were required for a proliferative response
to babesial antigens but not to the T-cell mitogen concanavalin A, suggesting that babesial proteins are not
simply mitogenic for T cells. Lymphocyte responses directed against a different hemoparasite from Mexico,
Babesia bigemina, indicate that this parasite shares cross-reactive T-cell epitopes with B. bovis. These studies
define a system whereby T lymphocytes from babesia-immune cattle can be used in proliferation assays to
identify babesial merozoite antigens which are immunogenic for T cells. Because identification of helper T-celi
epitopes is important for the design of a babesial subunit vaccine which will evoke anamnestic responses, the
studies described here provide a basis for such experiments.
Babesiosis is a major hemoparasitic disease of cattle in
semitropical regions of the world which results in severe
economic losses to the livestock industry. Transmitted by
the ixodid tick Boophilus microplus, Babesia bovis infec-
tions in susceptible cattle are characterized by fever, ano-
rexia and cachexia, low parasitemia, and a generalized
circulatory disturbance which includes sequestration of
parasitized erythrocytes in the capillary beds of the brain
and lung. Death is often caused by a respiratory distress
syndrome associated with massive infiltration of neutrophils
and parasitized erythrocytes into the lung capillaries, result-
ing in vascular permeability and edema (47, 48). Cytokines
released by parasite-activated T cells and monocytes are
most likely involved in the pathophysiology of this disease
(47, 48), as has been demonstrated with plasmodium-in-
fected mice (7, 14, 27).
Animals that survive natural infection, or recover from
experimental infection with attenuated parasites, are pro-
tected against virulent challenge (3), and partial immunity
against homologous and heterologous challenge can be in-
duced by vaccination with crude parasite extracts (24, 25)
and soluble culture-derived exoantigens (18, 28, 39, 42).
However, vaccination with living parasites poses a number
of problems, not the least of which is establishment of a
carrier state which permits continual babesial transmission.
These observations provide the basis for developing a non-
live vaccine for babesiosis.
Although antibody is important in controlling babesial
infection (23), antibody alone cannot account for the pat-
terns of immunity observed in response to infection and
challenge with heterologous B. bovis parasites (22) and does
not always correlate with protection (41). In addition to
providing B-cell help, T cells are the primary effector cells in
* Corresponding author.
protective immunity against many protozoal infections (9,
17, 29, 36, 37, 38), including Babesia microti infections (33).
Few published studies have examined the role of T lym-
phocytes in immunity to Babesia bovis. Timms et al. (43)
reported that peripheral blood mononuclear cells (PBMC)
from cattle protectively immunized with attenuated live
parasites exhibited weak and short-lived proliferative re-
sponses to a crude soluble parasite extract. Animals immu-
nized with exoantigen had stronger cell-mediated responses
but were less protected upon challenge. However, in both
groups of cattle, lymphocyte proliferation and antibody
responses correlated with protection when cattle were chal-
lenged at different times after vaccination. As a strategy for
developing vaccines which would include T-cell epitopes
important in the induction of a protective immune response
(6), we have focused our research on characterizing T-cell-
immunodominant antigens and T-cell responses in cattle
protectively immunized against B. bovis. In the studies
reported here, we have examined proliferative responses of
PBMC against crude membrane and soluble parasite extracts
and soluble exoantigen from cattle immunized with virulent
tick-derived parasites or avirulent cultured parasites. Vigor-
ous proliferation was observed in response to crude parasite
antigens for at least 2 years following challenge (as of this
writing). These experiments provide the basis for an in-depth
functional analysis of defined populations of T cells and
monocytes from these and other babesia-immune cattle in
response to defined babesial antigens.
MATERIALS AND METHODS
Babesial parasite strains and in vitro cultivation. The B.
bovis parasites used for in vivo infection and challenge
studies originated from a Mexican isolate, designated isolate
222, obtained from naturally infected cattle in a babesia-
endemic area of Mexico in 1978. Parasites were maintained
in a tick colony at the U.S. Department of Agriculture
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laboratory in Mission, Tex. In vitro erythrocyte cultures
derived from this isolate of B. bovis were maintained as
described by Holman et al. (16), using a modification of the
microaerophilus stationary-phase (MASP) culture system
(20). In vitro cultures of Babesia bigemina parasites were
maintained under the same culture conditions. The B.
bigemina parasites were obtained in 1982 from a naturally
infected animal in northeastern Mexico. Parasites were
passaged four times in splenectomized calves by subinocu-
lation of blood containing parasitized erythrocytes, and
washed, packed erythrocytes obtained during peak para-
sitemia were mixed with an equal volume of phosphate-
buffered saline (PBS) containing 4 M dimethyl sulfoxide
(Sigma Chemical Co., St. Louis, Mo.), aliquoted, and cryo-
preserved in liquid nitrogen. This parasite stock, or stabilate
(21), was then used to initiate the parasite cultures.
Experimental cattle. Animal C15, a spleen-intact, 2-year-
old European crossbred cow, was inoculated intravenously
two times, 1 month apart, with 2 x 106 and 4 x 106
erythrocytes derived from MASP cultures of autologous, B.
bovis-infected erythrocytes. Three years later, the cow was
inoculated again with 7 x 109 cultured parasitized erythro-
cytes, and PBMC were monitored thereafter for responses to
parasite antigens. Animals C97 and C88, 9-month-old spleen-
intact Brahman-European crossbred cows, were infected
with the Mexican isolate of B. bovis by infestation with B.
bovis-infected Boophilus microplus tick larvae (1 g; approx-
imately 20,000). Both animals experienced clinical babesio-
sis and were treated by intramuscular inoculation of dimina-
zene aceturate (Ganaseg; 3 mg/kg; Squibb and Sons, Mexico
City, Mexico) diluted in H20. Three months later, the
animals were challenged by intramuscular inoculation of 2.5
ml of ground-up tick stabilate (GUTS) prepared from B.
bovis-infected ticks collected from animal C97 on day 3
postinfection. GUTS was prepared in the following way.
Engorged ticks (2 g; approximately 10,000) were homoge-
nized with a loose-fitting Ten-Broeck tissue homogenizer in
15 ml of RPMI 1640 medium (GIBCO, Grand Island, N.Y.)
containing 3.5% bovine serum albumin. The homogenate
was centrifuged for 5 min at 250 x g, and the supernatant
was collected, layered over 3 ml of Ficoll-Hypaque (Histo-
paque-1077; Sigma), and centrifuged for 5 min at 150 x g.
The supernatant above the Ficoll-Hypaque interface was
collected, diluted in an equal volume of RPMI 1640 medium
containing 4 M dimethyl sulfoxide, aliquoted, and rapidly
frozen in liquid nitrogen. Animal C110, a spleen-intact,
9-month-old steer, served as a nonimmune control to assess
the virulence of the GUTS challenge. Age-matched animal
C99, a Brahman-European crossbred steer, served as a
noninfected control for all experiments. All cattle were
monitored daily for at least 2 weeks after infection for signs
of infection by determining rectal temperature, packed
erythrocyte volume (PCV), and peripheral parasitemia in
Giemsa-stained thin blood films.
Parasite antigens. Parasites were cultured at 37°C in 5%
CO2 in air in 24-well plates (1.25 ml; Costar, Cambridge,
Mass.) or in 25-cm2 flasks (12.5 ml; Costar) containing a 5%
(vol/vol) concentration of erythrocytes from animal C15 in
medium 199 (GIBCO) supplemented with 40% autologous
bovine serum. Merozoites were harvested following CO2
deprivation (46) of cultures after the relative percentage of
parasitized erythrocytes was increased by sequential reduc-
tion of the concentration of erythrocytes (13), with the
following modifications. Infected erythrocyte cultures con-
taining at least 15% parasitized erythrocytes were incubated
for 18 h in serum-free HL-1 medium (Ventrex Laboratories,
Inc., Portland, Maine) in 100% medical-grade oxygen at
37°C. Merozoites were recovered from the culture superna-
tant following a series of 10-min (140, 140, 180, and 220 x g)
and 15-min (5,000 x g) centrifugations of the supernatant,
followed by two 15-min (6,500 x g) centrifugations of the
parasite pellet resuspended in PBS. Merozoites prepared in
this manner contained some erythrocyte membranes but
were relatively pure. Culture supernatants collected from B.
bovis MASP cultures contain soluble parasite antigens des-
ignated exoantigens (32). The culture supernatant was col-
lected after the 5,000 x g centrifugation and is designated
ISUP. Supernatants prepared in the same way from autolo-
gous, uninfected cultured erythrocytes are designated
USUP. Merozoites (designated MER) were resuspended in
PBS containing the protease inhibitors E-64 and Antipain
(Boehringer Mannheim Biochemicals, Indianapolis, Ind.) at
25 ,ug/ml. To prepare subcellular fractions, merozoites col-
lected from 12 25-cm2 flasks were disrupted by two passages
through a French pressure cell (SLM Instruments, Inc.,
Urbana, Ill.) under a chamber pressure of 1,500 lb/in2, and
the homogenate was centrifuged for 1 h at 145,000 x g. The
soluble high-speed supernatant fraction (designated HSS
fraction) and membrane pellet resuspended in an equal
volume of PBS (designated CM fraction) were collected.
Fractions prepared in this manner generally yielded approx-
imately 6 mg of protein in the CM fraction and 3 mg of
protein in the HSS fraction. Ghosts prepared from unin-
fected erythrocytes (referred to as URBC) and a CM and
HSS fraction derived therefrom were also prepared. Protein
concentrations in the parasite or erythrocyte fractions were
determined as described previously (2), using bovine immu-
noglobulin G (Bio-Rad Laboratories, Richmond, Calif.) as a
protein standard. All fractions were stored at -80°C in
aliquots.
SDS-PAGE and Western blotting. Sodium dodecyl sulfate-
polyacrylamide gel electrophoresis (SDS-PAGE) was per-
formed as described previously (19), using a Bio-Rad minigel
apparatus, 10% acrylamide gels, and 10 ,ug of protein (con-
sisting of babesial or uninfected erythrocyte antigens) per
lane. Immunoblotting onto nitrocellulose was performed as
described previously (44) for 1 h at 100 V, using the Bio-Rad
Transblot apparatus. Blots were reacted with sera from
normal cattle (C99 or preinfection sera) or B. bovis-immune
cattle diluted 1:100 in Tris-buffered saline (10 mM Tris, 150
mM NaCl, pH 7.5) containing 1% gelatin, and serologically
reactive proteins were detected with a 1:5,000 dilution of
alkaline phosphatase-conjugated goat anti-bovine immuno-
globulin G (Kirkegaard & Perry Laboratories, Gaithersburg,
Md.) and substrates nitroblue tetrazolium and 5-bromo-4-
chloro-3-indolyl phosphate (Sigma) as instructed by the
manufacturers.
Lymphocyte proliferation assays. PBMC were prepared by
Ficoll-Hypaque density gradient centrifugation of blood di-
luted 1:1 in Alsever's solution (10). PBMC were tested for
reactivity to parasite antigens in a proliferation assay per-
formed for 5, 6, or 7 days. However, in one experiment,
lymphoproliferation was compared in duplicate assays har-
vested after 3 or 6 days. In another experiment, PBMC (2 x
106 cells per ml in a 25-cm2 flask at 37°C) were allowed to
adhere for 2 h to polystyrene, and the nonadherent fraction
of the cells was compared with unseparated PBMC for
lymphoproliferative responses. For all experiments, cells
were cultured in complete medium, which consisted of
RPMI 1640 medium containing 25 mM N-2-hydroxyethylpi-
perazine-N-2-ethanesulfonic acid (HEPES; GIBCO) and
supplemented with 10% heat-inactivated fetal bovine serum
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TABLE 1. Comparison of proliferative responses of normal and
immune PBMC cultured for 3 or 6 days with
B. bovis antigen or mitogen
Radioactivity (cpm) incorporated by PBMC with
Cattle indicated antigen or mitogen'
URBC CM B. bovis CM ConA
C99 (control)
Day 3 382 + 24 389 ± 30 28,750 ± 4,435
Day 6 431 ± 60 1,290 ± 715 40,306 ± 9,050
C15 (immune)
Day 3 1,011 ± 164 3,080 ± 294 119,530 ± 5,485
Day 6 3,683 ± 2,956 77,502 ± 8,798 59,202 ± 4,372
C97 (immune)
Day 3 480 ± 27 961 ± 165 126,858 ± 3,258
Day 6 673 ± 25 16,457 ± 3,990 55,182 ± 2,865
a A total of 2 x 105 PBMC were cultured in wells of half-area 96-well plates
with antigen or ConA. Background responses (medium) were always less than
the responses to URBC CM. After 3 or 6 days, the cells were radiolabeled for
4 h with '25IUDR and then harvested and counted as described in the text.
Results are means ± standard deviations of triplicate cultures. ConA was
present at a final concentration of 1 iLg/ml; URBC and B. bovis CM antigens
were present at a final concentration of 25 ,ug/ml.
_a 4
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FIG. 1. Serologic reactivity of B. bovis-immune sera with babe-
sial antigens. Western blots were performed by using preimmune
(lanes e to h) or postchallenge (lanes a to d) sera from animal C15 (A)
or C97 (B). (A) Lanes: a and h, URBC; b and g, parasite HSS; c and
f, parasite CM; d and e, MER. (B) Lanes: a and h, URBC; b and g,
MER; c and f, parasite CM; d and e, parasite HSS. Molecular size
standards are indicated on the left.
(Hyclone, Logan, Utah), 2 mM L-glutamine (GIBCO), 5 x
10-5 M 2-mercaptoethanol (Sigma), and 50 ,ug of gentamicin
sulfate (GIBCO) per ml. Proliferation assays were performed
in 96-well flat-bottom plates (200 [lI per well) or half-area
plates (100 RIl per well; Costar) with a final concentration of
2 x 106 PMBC per ml of complete medium. Concanavalin A
(ConA; Sigma) or antigen (B. bovis MER, CM, and HSS; B.
bigemina MER, URBC, and URBC CM) were added to the
assays at final concentrations of 0.2 to 25 Fg of protein per
ml of complete medium. Exoantigens (ISUP or USUP) were
added at a final concentration of 50 or 250 ,ug/ml. When
present, indomethacin (Sigma) was added to the assays at a
final concentration of 0.5 ,ug/ml. The cells were radiolabeled
for the last 4 or 18 h of culture with 0.25 or 0.5 ,uCi of
125iododeoxyuridine (125IUDR; ICN Biomedicals, Inc.,
Costa Mesa, Calif.) and harvested onto glass filters with an
automated cell harvester (Skatron Instruments, Inc., Ster-
ling, Va.). Proliferation was determined by measuring the
incorporation of 125IUDR by counting the radioactivity on
the filters in a gamma counter (Packard, Laguna Hills,
Calif.). Results are expressed as the mean radioactivity in
counts per minute of triplicate samples ± standard devia-
tion.
RESULTS
Clinical responses of cattle infected and challenged with B.
bovis. Animal C15, inoculated with autologous, cultured B.
bovis-infected erythrocytes, experienced mild signs of infec-
tion after the primary inoculation, with a 24% reduction in
PCV on day 7 postinoculation. There were no clinical signs
of babesiosis following the secondary and tertiary inocula-
tions. This cow was not treated with Ganaseg. Animals C88
and C97 developed severe babesiosis following infestation
with B. bovis-infected ticks. Parasites were observed in
blood films from C88 on days 8 to 13 postinfestation, and on
day 10 the PCV was reduced by 48%. Parasites were
detected in blood films from C97 on days 13 and 14 postin-
festation, and on day 13 the PCV fell by 50%. Both animals
were treated with Ganaseg. Three months later, C88 and C97
were challenged with an infective tick stabilate, and both
animals were solidly immune to challenge. They experienced
no reduction in PCV, whereas the nonimmune control ani-
mal C110 experienced severe babesiosis with a 57% reduc-
tion in PCV on day 14 postinoculation. This animal recov-
ered without treatment.
Serologic responses of B. bovis-infected cattle. All four
animals were serologically positive for B. bovis, as deter-
mined by indirect immunofluorescence staining of smears of
cultured parasites (not shown). Postchallenge sera from all
animals reacted on immunoblots with numerous bands
present in whole merozoites and soluble and membrane
subfractions of merozoites, whereas there was no reactivity
against proteins present in uninfected, cultured erythro-
cytes. Figure 1 is an immunoblot of preimmune (lanes e to h)
and postchallenge (lanes a to d) sera of animals C15 (Fig. 1A)
and C97 (Fig. 1B) incubated with URBC and B. bovis MER,
CM, and HSS. Major protein bands in the MER recognized
by C97 antiserum had approximate molecular masses of 42,
60, 85, 120, and 225 kDa (Fig. 1B, lane b), whereas C15
immune serum reacted most strongly with bands of 42 and
116 kDa (Fig. 1A, lane d). Several protein bands recognized
by immune sera from C15 and C97 were present in both
soluble and membrane fractions, including the immunodom-
inant 42-kDa (12, 15), 60-kDa (12, 40), and 85-kDa (12)
proteins. Serum from normal animal C99 did not react with
any babesial protein, and none of the sera reacted with B.
bigemina merozoites on immunoblots (data not shown).
Examination of babesia-specific proliferative responses over
time. To determine the optimal assay time for babesia-
specific responses, proliferation assays of control (C99) or
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FIG. 2. Time course of the proliferative response of PBMC from B. boiis-immune cattle. PBMC (4 x 105) from immune cattle were
assessed for proliferative responses against B. bovis MER (gray bars), URBC (white bars), or medium control (black bars) at various weeks
following the last challenge inoculation as indicated on the abscissa. Cells were cultured for 6 or 7 days with indomethacin, radiolabeled for
4 h, harvested, and counted as described in the text. The data shown are for optimal concentrations of URBC or MER antigen in the culture
wells, which were as follows: C88, 6.2 ,ug/ml; C97, 25 ,ug/ml; C15, 1.0 to 6.2 ,ug/ml; and C110, 25 ,ug/ml.
immune (C97 and C15) PBMC were performed for 3 or 6
days (Table 1). There was no response to URBC at either
day. Little or no reactivity against babesial antigen had
occurred by day 3, but strong responses were present by day
6. In contrast, strong responses to the T-cell mitogen ConA
were present by day 3. Subsequent assays were conducted
for 5 to 7 days.
Immune cattle were monitored for proliferative responses
to babesial and control antigens for weeks or months follow-
ing the last challenge inoculation. Figure 2 presents the
responses of PBMC from the four immunized cattle to
optimal antigen concentrations of purified merozoites or
uninfected erythrocytes on various weeks after challenge.
Vigorous proliferative responses to unfractionated merozo-
ites were consistently observed with C15 and C110 PBMC
after 10 to 15 weeks postchallenge. Animals C88 and C97 had
inconsistent and often undetectable responses to merozoites
over time. However, responses to the CM fraction were
consistently positive in all immune animals and after 2 years
could still be induced in PBMC from animals C97 and C15,
which were chosen for prolonged study.
Differential responses of PBMC from babesia-sensitized
cattle to different antigenic fractions. PBMC from B. bovis-
immune and control cattle were compared for stimulation by
different crude preparations of uninfected erythrocytes and
B. bovis merozoites. Figure 3 compares proliferation of
PBMC from three immune cattle and normal animal C99
against four concentrations of URBC, MER, CM, and HSS
fractions. PBMC from all animals were unresponsive to
URBC (Fig. 3) and soluble and membrane fractions prepared
from URBC (not shown). PBMC from all immune cattle
responded vigorously to the parasite CM fraction in a
dose-dependent manner, with maximal proliferation occur-
ring at a concentration of 25 ,ug of protein per ml. Soluble
HSS was weakly stimulatory for C97 PBMC and moderately
stimulatory for C110 PBMC, but it induced strong responses
in C15 PBMC at the higher concentrations of antigen (5 and
25 ,ug of protein per ml). MER induced intermediate levels of
proliferation in C97 and C110 PBMC, in a dose-dependent
fashion, whereas the proliferative response of C15 PBMC to
MER was routinely highest with the lowest concentration of
protein assayed (in this case, 0.2 ,ug/ml). Occasional re-
sponses of control C99 lymphocytes to CM or HSS antigen
were observed, but these responses were neither consistent
nor dose dependent. Nevertheless, the possibility that mero-
zoites contain mitogenic components must be considered.
Effect of indomethacin on parasite-specific responses. We
observed large, activated mononuclear cells in cultures of
PBMC stimulated with merozoites. This, together with the
finding that high concentrations of merozoite antigen had an
inhibitory effect on proliferation of C15 PBMC (Fig. 3),
prompted us to test the effect of the prostaglandin E2 (PGE2)
inhibitor indomethacin on parasite-induced proliferation. At
a final concentration of 0.5 ,ug/ml, indomethacin has been
I
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FIG. 3. Dose-dependent proliferative responses against merozoite fractions. PBMC (4 x 105) from one normal (C99) and three immune
cattle were stimulated for 6 days with a final concentration of 0.2, 1, 5, or 25 ,ug of protein per ml of URBC (solid circles), B. bovis MER (open
circles), B. bovis CM (triangles), or B. bovis HSS (squares). Indomethacin was included in the assay.
shown to augment interleukin-2 (IL-2) production by bovine
T cells (35). When added to proliferation assays, this con-
centration of indomethacin enhanced the responses of
PBMC from all immune cattle to MER and the CM fraction;
an eightfold increase was observed in the proliferation of
C97 PBMC to CM with indomethacin (Table 2). There was
less effect on the response to HSS and no effect on the
response to URBC.
Inhibitory effect of merozoites. Because the CM fraction
from merozoites induced higher levels of proliferation than
intact merozoites, the possibility that merozoites were inhib-
itory or induced a downregulation of a proliferative response
was examined. The effect of MER or URBC antigen on
ConA-induced blastogenesis of normal and immune PBMC
is shown in Fig. 4. With PBMC from three animals (C99,
C97, and C15), there was negligible (5% or less) inhibition of
the response to ConA alone when URBC was added with
ConA to the assay wells. However, when MER was added
with ConA in the assay, inhibition of the ConA response
ranged from 46 to 54%. The ConA response of PBMC from
the fourth animal (C110) was inhibited 12% by URBC and
34% by MER. The inhibition of the ConA response by MER
was evident in 6-day (Fig. 4) but not 3-day assays, and
inhibition by either the CM or HSS fraction was not appre-
ciably different from that by URBC (not shown).
Proliferative responses to soluble culture supernatant anti-
gens. Supernatants from cultures containing a high percent-
age of parasitized erythrocytes or uninfected erythrocytes
were compared for antigenic activity at a protein concentra-
TABLE 2. Effect of indomethacin on cell-mediated
immune responses
Antigen or Radioactivity (cpm) incorporated by PBMCb
mitogen' C15 C97 Ci1o
Medium
Alone 1,004 ± 102 1,084 ± 180 839 ± 22
+ Indo 2,676 ± 167 1,151 ± 99 1,013 ± 150
ConA
Alone 129,173 ± 1,809 115,148 ± 3,543 41,867 ± 249
+ Indo 145,463 ± 247 126,690 ± 4,119 80,954 ± 3,107
URBC
Alone 1,117 ± 114 912 ± 72 829 ± 174
+ Indo 2,965 ± 495 1,050 ± 85 980 ± 31
MER
Alone 52,666 ± 4,475 2,005 ± 210 22,365 ± 3,910
+ Indo 91,004 ± 9,444 4,445 + 1,582 40,506 ± 10,348
CM
Alone 87,066 ± 909 6,745 ± 1,450 24,187 ± 334
+ Indo 140,492 ± 2,034 55,564 ± 7,627 52,324 ± 4,948
HSS
Alone 78,908 ± 2,965 1,669 ± 577 7,476 ± 164
+ Indo 144,425 ± 8,729 2,505 ± 1,268 8,204 ± 590
a ConA and antigen were present at a final concentration of 5 jig/ml, and
indomethacin (Indo) was included in some wells.
b A total of 4 x 105 PBMC from three B. bovis-immune cattle were cultured
with medium, antigen, or ConA for 5 (C15 and C97) or 7 (C110) days,
radiolabeled for 4 h, and harvested as described in the text. Results are means
+ standard deviations of triplicate cultures.
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TABLE 3. Proliferative responses of PBMC to
B. bigemina merozoites
Radioactivity (cpm) incorporated
Antigen and concn by PBMC'
(pLg/ml)
C15 C97
Medium 966 ± 308 647 ± 66
URBC CM
5 626 83 777 316
25 834 ± 391 535 ± 33
B. bovis CM
5 20,396 ± 1,422 3,421 ± 1,141
25 22,831 ± 756 8,147 ± 3,596
B. bigemina MER
5 15,703 ± 1,786 5,018 ± 1,623
25 14,386 ± 1,948 793 ± 262
0 1 0 20 30 40 50 60 a A total of 2 x 105 PBMC were cultured in half-area 96-well plates with
antigen for 6 days, radiolabeled for 4 h with 125IUDR, harvested, and counted
PERCENTAGE INHIBITION as described in the text. All wells contained indomethacin. Results are means
standard deviations of trinlicate cultures
FIG. 4. Inhibition of ConA-induced proliferation by merozoites.
PBMC (4 x 105) from one normal (C99) and three immune cattle
were stimulated for 6 days with ConA (at a final concentration of 1
p.g/ml), MER (at a final concentration of 25 ,ug/ml), URBC (at a final
concentration of 25 ,ug/ml), or a combination of ConA plus MER or
ConA plus URBC. Percent inhibition of the proliferative response to
ConA alone is shown for PBMC cultured with ConA plus MER
(hatched bars) and ConA plus URBC (white bars). Indomethacin
was included in the assay.
tion of 250 ,ug/ml (Fig. 5). PBMC from animal C15, which
was immunized with cultured parasites, were consistently
responsive to ISUP and, at a protein concentration of 50
,ug/ml, incorporated 36,715 ± 3,403 cpm. In contrast, PBMC
from cattle infected with tick-derived parasites (C97 and
C110) did not respond to the lower antigen concentration and
responded only weakly to the higher concentration of ISUP.
Proliferative responses to unrelated B. bigemina merozoites.
B. bigemina merozoites also induced proliferation of PBMC
80
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FIG. 5. Proliferative responses to culture supernatant antigen.
PBMC from one normal (C99) and three immune cattle were
stimulated for 6 days with medium alone (black bars) or with
supernatants USUP (white bars) or ISUP (gray bars). The responses
shown were elicited with a final protein concentration of 250 p.g/ml.
Indomethacin was included in the assay.
from animals C15 and C97, although these animals were
serologically unreactive with this parasite on immunoblots.
The response of C15 PBMC was always vigorous to this
parasite, whereas the response of C97 PBMC was routinely
weaker (Table 3).
Role of monocytes/macrophages in the response to babesial
antigens. Other protozoan parasites, including Plasmodium
falciparum (45, 49) and Theileria parva (1, 11, 30, 31), have
been shown to induce nonspecific lymphocyte proliferation.
To examine the possibility that babesial parasites were also
mitogenic, PBMC depleted of monocytes by 2 h of adher-
ence to polystyrene (10) were compared with unseparated
PBMC for the ability to respond to Babesia antigen or ConA
(Table 4). Adherent cells were required for a babesia-specific
response in both immune animals but not for a mitogenic
response to ConA. In undepleted PBMC, both specific and
nonspecific responses were markedly enhanced by the addi-
tion of indomethacin. However, in monocyte-depleted cells,
indomethacin had little effect on the ConA response and no
effect on the babesia-specific response. These data suggest
that monocytes/macrophages are required as antigen-pre-
senting cells for the induction of lymphocyte blastogenesis to
babesial antigens.
DISCUSSION
The results of this study demonstrate that infection of
cattle with B. bovis-infected ticks, tick stabilate, or cultured
merozoites elicits strong, cell-mediated immune responses
to merozoite antigens. All four immunized animals, but not
the control animal, responded to parasite antigens in a
dose-dependent manner. Animals C15 and C97 have been
monitored for 2 years since the last parasite inoculation, and
they continue to respond vigorously to parasite antigen.
Since both animals received viable parasites upon challenge,
these long-lived responses may be due to chronic infection
and continual release of parasite antigen or to a memory
T-cell response.
When the proliferative responses against crude, subcellu-
lar fractions of merozoites were compared, we found that
cattle infected with tick-derived parasites preferentially re-
sponded to an antigenic fraction enriched in parasite mem-
branes. In contrast, the animal that was inoculated with
cultured merozoites responded vigorously to the membrane-
enriched fraction, the soluble merozoite fraction, and solu-
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TABLE 4. Requirement of plastic-adherent PBMC for
B. bovis-specific proliferative responses
Radioactivity (cpm) incorporated by PBMC with
Cattle and indicated antigen or mitogen'
PBMC
Medium B. bovis MER ConA
C88
Unseparated
Alone 2,022 ± 297 4,517 + 656 51,905 ± 676
+ Indob 7,424 ± 2,954 35,580 ± 7,752 119,952 ± 3,966
Nonadherent'
Alone 793 ± 86 1,026 ± 123 111,483 ± 1,368
+ Indo 716 ± 66 881 ± 117 117,363 + 3,240
C97
Unseparated
Alone 8,875 ± 110 48,749 ± 8,945 62,056 ± 2,364
+ Indo 7,231 ± 958 71,027 + 7,504 98,306 ± 5,355
Nonadherent
Alone 438 + 38 705 ± 123 84,387 ± 5,595
+ Indo 279 ± 197 660 ± 155 91,160 ± 5,270
a A total of 4 x 105 PBMC were cultured in 96-well plates with medium,
antigen, or ConA for 7 days. The cells were radiolabeled for 18 h with
1251UDR, harvested, and counted as described in the text. Results are means
± standard deviations of triplicate cultures. ConA was present at a final
concentration of 5 ,ug/ml; B. bovis MER antigen was present at a final
concentration of 6.2 jig/ml.b Indomethacin (Indo) was included in the assay.
c A total of 5 x 107 PBMC were incubated for 2 h at 37°C in a 25-cm2 flask
(10 ml), and the nonadherent cells were used in the assay.
ble culture supernatant antigens. Responses of animals C97
and C110 to the soluble merozoite fraction were weaker,
even in the presence of indomethacin, and these cattle did
not react significantly with culture supernatant exoantigens.
These studies suggest that antigens most immunogenic for T
cells, and those which induce an anamnestic response from
cattle exposed to babesia-infected ticks, are found in para-
site membrane-enriched fractions. Soluble antigens and an-
tigens secreted or shed into the culture supernatant most
likely contain some of these membrane-associated proteins,
as shown by the reactivity on immunoblots of immune sera
with protein bands common to CM and HSS fractions.
However, the use of soluble parasite extracts to induce
T-cell blastogenesis may explain the weak and short-lived
responses in B. bovis-immune cattle observed by Timms and
coworkers (43). Furthermore, the unique response ofPBMC
from animal C15 to culture supernatant antigens may be
directed primarily against cultured merozoite antigens used
for immunization. The response of B. bovis-immune PBMC
to B. bigemina parasites is likely directed against epitopes
shared by the two parasites, and species-common polypep-
tides have been demonstrated by immunoprecipitation with
immune sera (26). The lack of serological reactivity on
immunoblots with C97 and C15 immune sera may reflect a
difference in T- and B-cell epitopes on these putative cross-
reactive proteins.
The optimal time of 5 to 7 days for blastogenesis to occur
in response to babesial antigen is consistent with an antigen-
induced and not a mitogen-induced response. Furthermore,
comparison of proliferative responses from immune and
normal cattle indicates that these responses were evoked in
an antigen-specific manner, since babesial antigens stimu-
lated little or no proliferation in PBMC from the nonimmune
control. Additional evidence for the antigen-specific nature
of the proliferative response was demonstrated by the inabil-
ity of PBMC depleted of plastic-adherent cells to respond to
antigen, with no reduction in the response to ConA. Because
the majority of monocytes are removed by this procedure
(10), these results indicate that monocytes are required as
antigen-presenting cells in the babesia-specific response.
The regulation of lymphocyte proliferation in response to
babesial antigens appears quite complex. As well as the
apparent requirement for monocytes as accessory or anti-
gen-presenting cells, monocytes appear to inhibit immune
responses through the production of PGE2. This autocoid
has been shown to play a key role in immune downregulation
by inhibiting both IL-1 and IL-2 production (reviewed in
references 4 and 8), possibly through the induction of
suppressor T cells (5). In our studies, the PGE2 inhibitor
indomethacin enhanced both babesia-specific and ConA
responses but did not reverse the inability of uninfected
erythrocyte membranes to stimulate PBMC. An interpreta-
tion of these results is that babesial merozoite antigens
induce the production of PGE2 by monocytes, which may
downregulate IL-1- and IL-2-induced lymphocyte prolifera-
tive responses. Our findings are consistent with those of
Ruebush and coworkers (34), who showed that B. microti
infection of mice elicited PGE2 synthesis by macrophages,
which resulted in suppression of delayed-type hypersensitiv-
ity responses to parasite antigens.
Unfractionated merozoites both stimulated proliferation
of antigen-primed lymphocytes and inhibited the prolifera-
tive response to the T-cell mitogen ConA. This inhibitory
effect was observed in the presence or absence of indometh-
acin, implying that factors in addition to PGE2 are involved
in suppressing proliferation. We are exploring the possibility
that tumor necrosis factor alpha, released by parasite-acti-
vated macrophages, may play a role in downregulating T-cell
proliferation. Inhibition of ConA-induced proliferation was
not caused by antigen-specific T cells, since PBMC from
nonimmune animal C99 were inhibited to the same extent as
those from babesia-sensitized animals. Soluble factors pro-
duced by T. parva-infected T cells were similarly shown to
suppress proliferation of T cells from normal cattle (11).
These studies provide a foundation for further analyses of
the cellular immune response which is undoubtedly involved
in protective immunity against Babesia spp. and all hemo-
parasites. To unravel the complex interactions between host
lymphocytes, monocytes, and parasite antigens, defined
subpopulations of T cells and biochemically purified or
recombinant parasite antigens must be used. Experiments
designed to identify T-cell-immunodominant babesial anti-
gens by using functionally characterized babesia-specific
T-cell lines and clones are in progress and will be the subject
of future publications.
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